Recent studies reported an association between ARID1A mutations and high TMB status in various types of cancer, including colorectal cancer [33,34,35], ovarian clear cell carcinoma (OCCC) [36], gastroesophageal cancer, non-small cell lung cancer, and endometrial cancer [34]. The gene discussed is ARID1A; the disease is ovarian clear cell cancer.